MedPath

Effects of the Clinical Application of Traditional, Complementary and Integrative Medicine (TCIM) Procedures During Inpatient Stays in Germany

Recruiting
Conditions
Chronic Disease
Registration Number
NCT07040475
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

The aim of this healthcare research project is to evaluate the effects of routine inpatient TCIM (Traditional, Complementary and Integrative Medicine) care in Germany. The focus is on the TCIM centers at Immanuel Krankenhaus Berlin, Klinikum Bamberg und Evang. Kliniken Essen-Mitte, where inpatient TCIM therapies are to be systematically evaluated. This form of therapy, which is reimbursed by statutory health insurance providers (under certain conditions), is based on a combination of various evidence-based TCIM approaches. These include hyperthermia, exercise therapy, Mind-Body Medicine, phytotherapy, nutritional therapy, fasting therapy inter alia.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2500
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Short Form Health Survey - 12 Items (SF-12)Baseline, 3 months

0-100, higher scores indicate better health status.

Secondary Outcome Measures
NameTimeMethod
Short Form Health Survey - 12 Items (SF-12)Baseline, up to 14 days, 6 months, 12 months

0-100, higher scores indicate better health status.

EuroQol 5-Dimension 5-LevelBaseline, up to 14 days, 3 months, 6 months, 12 months

0 (worst) to 1 (best), higher scores indicate better health-related quality of life.

Food Frequency ListBaseline, up to 14 days, 3 months, 6 months, 12 months

Descriptive measure; not scored on a numeric scale.

International Physical Activity Questionnaire - Short FormBaseline, up to 14 days, 3 months, 6 months, 12 months

MET-min/week (variable), higher scores indicate higher physical activity levels.

Hospital Anxiety and Depression ScaleBaseline, up to 14 days, 3 months, 6 months, 12 months

0-21 per subscale (Anxiety and Depression), higher scores indicate more severe symptoms.

Work Productivity and Activity Impairment QuestionnaireBaseline, 3 months, 6 months, 12 months

0%-100%, higher scores indicate greater impairment (i.e., worse outcome).

Perceived Stress Scale - 4Baseline, up to 14 days, 3 months, 6 months, 12 months

0-16, higher scores indicate higher perceived stress.

Main complaintBaseline, up to 14 days, 3 months, 6 months, 12 months

Visual Analog Scale (0-100, higher scores mean a worse outcome)

Fibromyalgia Impact QuestionnaireBaseline, up to 14 days, 3 months, 6 months, 12 months

0-100, higher scores indicate greater impact of fibromyalgia (worse outcome).

Rheumatoid Arthritis Disease Activity IndexBaseline, up to 14 days, 3 months, 6 months, 12 months

0-10, higher scores indicate greater disease activity (worse outcome).

Bath Ankylosing Spondylitis Disease Activity IndexBaseline, up to 14 days, 3 months, 6 months, 12 months

0-10, higher scores indicate more active disease (worse outcome).

Bath Ankylosing Spondylitis Functional IndexBaseline, up to 14 days, 3 months, 6 months, 12 months

0-10, higher scores indicate more functional limitation (worse outcome).

Western Ontario and McMaster Universities Osteoarthritis IndexBaseline, up to 14 days, 3 months, 6 months, 12 months

0-100, higher scores indicate greater pain/stiffness/disability (worse outcome).

Irritable Bowel Syndrome Symptom Severity ScoreBaseline, up to 14 days, 3 months, 6 months, 12 months

0-500, higher scores indicate more severe IBS symptoms (worse outcome).

Short Inflammatory Bowel Disease QuestionnaireBaseline, up to 14 days, 3 months, 6 months, 12 months

10-70, higher scores indicate better quality of life.

Pain Disability IndexBaseline, up to 14 days, 3 months, 6 months, 12 months

0-70, higher scores indicate greater disability (worse outcome).

Roland Morris Disability QuestionnaireBaseline, up to 14 days, 3 months, 6 months, 12 months

0-24, higher scores indicate more severe disability (worse outcome).

Maslach Burnout InventoryBaseline, up to 14 days, 3 months, 6 months, 12 months

Variable by subscale (Emotional Exhaustion: 0-54, Depersonalization: 0-30, Personal Accomplishment: 0-48) Higher scores on EE/DP = worse outcome; higher PA = better outcome.

Beck Depression Inventory-IIBaseline, up to 14 days, 3 months, 6 months, 12 months

0-63, higher scores indicate more severe depressive symptoms (worse outcome).

Diabetes Distress Scale - 17Baseline, up to 14 days, 3 months, 6 months, 12 months

1-6, higher scores indicate greater emotional distress related to diabetes (worse outcome).

Dermatology Life Quality IndexBaseline, up to 14 days, 3 months, 6 months, 12 months

0-30, higher scores indicate greater impact on quality of life (worse outcome).

Functional Assessment of Cancer Therapy - GeneralBaseline, up to 14 days, 3 months, 6 months, 12 months

0-108, higher scores indicate better quality of life.

Use of the healthcare systemBaseline,12 months

Descriptive data (e.g., number of visits); not a scored scale.

Expectations regarding inpatient TCIM treatmentBaseline

5-point Likert scale, 1-5. Higher scores indicate stronger or more positive expectations.

Chalder Fatigue ScaleBaseline, up to 14 days, 3 months, 6 months, 12 months

0-33, higher scores mean a worse outcome

Somatic Symptom ScaleBaseline, up to 14 days, 3 months, 6 months, 12 months

0-32, higher scores mean a worse outcome

Body weight [kg]Baseline, up to 14 days
Height [in cm]Baseline
BMI [kg/m2]Baseline, up to 14 days
Systolic blood pressure [mmHg], diastolic blood pressure [mmHg]Baseline, up to 14 days
Waist circumference [in cm]Baseline, up to 14 days
Triglycerides [mg/dl]Baseline, up to 14 days
Total cholesterol [mg/dl]Baseline, up to 14 days
HDL [mg/dl]Baseline, up to 14 days
LDL [mg/dl]Baseline, up to 14 days
Glucose [mg/dl]Baseline, up to 14 days
Uric acid [μmol/L]Baseline, up to 14 days
Creatinine [mg/dl]Baseline, up to 14 days
CRP [mg/l]Baseline, up to 14 days
GPT [U/l]Baseline, up to 14 days
HbA1c [mmol/mol]Baseline, up to 14 days
HbA1c [%]Baseline, up to 14 days

Trial Locations

Locations (3)

Sozialstiftung Bamberg, Klinikum Bamberg

🇩🇪

Bamberg, Germany

Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

Klinik für Naturheilkunde und Integrative Medizin, KEM

🇩🇪

Essen, Germany

Sozialstiftung Bamberg, Klinikum Bamberg
🇩🇪Bamberg, Germany
Jost Langhorst, Prof. Dr.
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.